eClinical Tech News

Nurexone Biologic reported new preclinical data for ExoPTEN, an exosome-delivered siRNA therapy targeting PTEN, showing a reproducible, dose-dependent restoration...

Nasus Pharma has signed comprehensive agreements with Aptar to support clinical development and planned commercialization of NS002, an intranasal...

Novo Nordisk has agreed to acquire Akero Therapeutics for up to $5.2 billion in cash, adding the FGF21 analogue...

Assembly Biosciences reported interim Phase 1b results for its long-acting HSV helicase-primase inhibitor ABI-5366, presented as a late-breaking oral...

60 Degrees Pharmaceuticals will initiate B-FREE, a Phase 2 open-label study of tafenoquine (marketed as Arakoda for malaria prophylaxis)...

FDA has approved Lasix Onyu, a subcutaneous, high‑concentration furosemide drug–device combination for treating edema due to fluid overload in...

Boehringer Ingelheim has secured FDA approval for Jascayd (nerandomilast), an oral, first-in-class preferential PDE4B inhibitor for adults with idiopathic...

ARS Pharmaceuticals secured a significant intellectual property win in Europe, with the European Patent Office’s Opposition Division upholding all...

Abeona Therapeutics has activated Children’s Hospital Colorado as a qualified treatment center for Zevaskyn (prademagene zamikeracel), the first FDA-approved...

Newcastle University has partnered with Curium to establish a PET radiopharmaceutical manufacturing site in Newcastle, expected to be operational...